(2R,5S)-6-(4-fluorophenyl)-5-methyl-2-(2-methylpropyl)-4-oxo-N-[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]hexanamide;N-[(2S,5R)-1-(4-fluorophenyl)-7-methyl-3-oxo-5-[[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]pyrazine-2-carboxamide;5-methyl-N-[(2S,5R)-7-methyl-1-naphthalen-1-yl-3-oxo-5-[[1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]-1,2-oxazole-3-carboxamide;(2R)-4-methyl-2-[2-(5-methyl-1,2-oxazol-3-yl)-2-oxoethyl]-N-[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]pentanamide

C109H141F2N11O20 — CID 160724646

IUPAC(2R,5S)-6-(4-fluorophenyl)-5-methyl-2-(2-methylpropyl)-4-oxo-N-[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]hexanamide;N-[(2S,5R)-1-(4-fluorophenyl)-7-methyl-3-oxo-5-[[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]pyrazine-2-carboxamide;5-methyl-N-[(2S,5R)-7-methyl-1-naphthalen-1-yl-3-oxo-5-[[1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]-1,2-oxazole-3-carboxamide;(2R)-4-methyl-2-[2-(5-methyl-1,2-oxazol-3-yl)-2-oxoethyl]-N-[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]pentanamide
SMILESCC(C)C[C@H](CC(=O)[C@@H](C)Cc1ccc(F)cc1)C(=O)N[C@H](C=O)C[C@@H]1CCNC1=O.CC(C)C[C@H](CC(=O)[C@H](Cc1ccc(F)cc1)NC(=O)c1cnccn1)C(=O)N[C@H](C=O)C[C@@H]1CCCCC1=O.Cc1cc(C(=O)C[C@@H](CC(C)C)C(=O)N[C@H](C=O)C[C@@H]2CCCCC2=O)no1.Cc1cc(C(=O)N[C@@H](Cc2cccc3ccccc23)C(=O)C[C@@H](CC(C)C)C(=O)NC(C=O)C[C@@H]2CCCCC2=O)no1
InChIInChI=1S/C34H41N3O6.C30H37FN4O5.C24H33FN2O4.C21H30N2O5/c1-21(2)15-26(33(41)35-27(20-38)17-25-10-5-7-14-31(25)39)19-32(40)29(36-34(42)30-16-22(3)43-37-30)18-24-12-8-11-23-9-4-6-13-28(23)24;1-19(2)13-22(29(39)34-24(18-36)15-21-5-3-4-6-27(21)37)16-28(38)25(14-20-7-9-23(31)10-8-20)35-30(40)26-17-32-11-12-33-26;1-15(2)10-19(13-22(29)16(3)11-17-4-6-20(25)7-5-17)24(31)27-21(14-28)12-18-8-9-26-23(18)30;1-13(2)8-16(11-20(26)18-9-14(3)28-23-18)21(27)22-17(12-24)10-15-6-4-5-7-19(15)25/h4,6,8-9,11-13,16,20-21,25-27,29H,5,7,10,14-15,17-19H2,1-3H3,(H,35,41)(H,36,42);7-12,17-19,21-22,24-25H,3-6,13-16H2,1-2H3,(H,34,39)(H,35,40);4-7,14-16,18-19,21H,8-13H2,1-3H3,(H,26,30)(H,27,31);9,12-13,15-17H,4-8,10-11H2,1-3H3,(H,22,27)/t25-,26+,27?,29-;21-,22+,24-,25-;16-,18-,19+,21-;15-,16+,17-/m0000/s1
InChIKeyRTNWPJPCMPEHGL-NOXPZLBESA-N
MW1963.38 g/mol
LogP14.23
Rot. Bonds50

About (2R,5S)-6-(4-fluorophenyl)-5-methyl-2-(2-methylpropyl)-4-oxo-N-[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]hexanamide;N-[(2S,5R)-1-(4-fluorophenyl)-7-methyl-3-oxo-5-[[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]pyrazine-2-carboxamide;5-methyl-N-[(2S,5R)-7-methyl-1-naphthalen-1-yl-3-oxo-5-[[1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]-1,2-oxazole-3-carboxamide;(2R)-4-methyl-2-[2-(5-methyl-1,2-oxazol-3-yl)-2-oxoethyl]-N-[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]pentanamide

(2R,5S)-6-(4-fluorophenyl)-5-methyl-2-(2-methylpropyl)-4-oxo-N-[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]hexanamide;N-[(2S,5R)-1-(4-fluorophenyl)-7-methyl-3-oxo-5-[[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]pyrazine-2-carboxamide;5-methyl-N-[(2S,5R)-7-methyl-1-naphthalen-1-yl-3-oxo-5-[[1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]-1,2-oxazole-3-carboxamide;(2R)-4-methyl-2-[2-(5-methyl-1,2-oxazol-3-yl)-2-oxoethyl]-N-[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]pentanamide (PubChem CID 160724646) has the molecular formula C109H141F2N11O20 and a molecular weight of 1963.38 g/mol. Its IUPAC name is (2R,5S)-6-(4-fluorophenyl)-5-methyl-2-(2-methylpropyl)-4-oxo-N-[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]hexanamide;N-[(2S,5R)-1-(4-fluorophenyl)-7-methyl-3-oxo-5-[[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]pyrazine-2-carboxamide;5-methyl-N-[(2S,5R)-7-methyl-1-naphthalen-1-yl-3-oxo-5-[[1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]-1,2-oxazole-3-carboxamide;(2R)-4-methyl-2-[2-(5-methyl-1,2-oxazol-3-yl)-2-oxoethyl]-N-[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]pentanamide.

Molecular Properties

Compound Name(2R,5S)-6-(4-fluorophenyl)-5-methyl-2-(2-methylpropyl)-4-oxo-N-[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]hexanamide;N-[(2S,5R)-1-(4-fluorophenyl)-7-methyl-3-oxo-5-[[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]pyrazine-2-carboxamide;5-methyl-N-[(2S,5R)-7-methyl-1-naphthalen-1-yl-3-oxo-5-[[1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]-1,2-oxazole-3-carboxamide;(2R)-4-methyl-2-[2-(5-methyl-1,2-oxazol-3-yl)-2-oxoethyl]-N-[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]pentanamide
PubChem CID160724646
Molecular FormulaC109H141F2N11O20
Molecular Weight1963.38 g/mol
Exact Mass1962.03
IUPAC Name(2R,5S)-6-(4-fluorophenyl)-5-methyl-2-(2-methylpropyl)-4-oxo-N-[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]hexanamide;N-[(2S,5R)-1-(4-fluorophenyl)-7-methyl-3-oxo-5-[[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]pyrazine-2-carboxamide;5-methyl-N-[(2S,5R)-7-methyl-1-naphthalen-1-yl-3-oxo-5-[[1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]-1,2-oxazole-3-carboxamide;(2R)-4-methyl-2-[2-(5-methyl-1,2-oxazol-3-yl)-2-oxoethyl]-N-[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]pentanamide
SMILESCC(C)C[C@H](CC(=O)[C@@H](C)Cc1ccc(F)cc1)C(=O)N[C@H](C=O)C[C@@H]1CCNC1=O.CC(C)C[C@H](CC(=O)[C@H](Cc1ccc(F)cc1)NC(=O)c1cnccn1)C(=O)N[C@H](C=O)C[C@@H]1CCCCC1=O.Cc1cc(C(=O)C[C@@H](CC(C)C)C(=O)N[C@H](C=O)C[C@@H]2CCCCC2=O)no1.Cc1cc(C(=O)N[C@@H](Cc2cccc3ccccc23)C(=O)C[C@@H](CC(C)C)C(=O)NC(C=O)C[C@@H]2CCCCC2=O)no1
InChIInChI=1S/C34H41N3O6.C30H37FN4O5.C24H33FN2O4.C21H30N2O5/c1-21(2)15-26(33(41)35-27(20-38)17-25-10-5-7-14-31(25)39)19-32(40)29(36-34(42)30-16-22(3)43-37-30)18-24-12-8-11-23-9-4-6-13-28(23)24;1-19(2)13-22(29(39)34-24(18-36)15-21-5-3-4-6-27(21)37)16-28(38)25(14-20-7-9-23(31)10-8-20)35-30(40)26-17-32-11-12-33-26;1-15(2)10-19(13-22(29)16(3)11-17-4-6-20(25)7-5-17)24(31)27-21(14-28)12-18-8-9-26-23(18)30;1-13(2)8-16(11-20(26)18-9-14(3)28-23-18)21(27)22-17(12-24)10-15-6-4-5-7-19(15)25/h4,6,8-9,11-13,16,20-21,25-27,29H,5,7,10,14-15,17-19H2,1-3H3,(H,35,41)(H,36,42);7-12,17-19,21-22,24-25H,3-6,13-16H2,1-2H3,(H,34,39)(H,35,40);4-7,14-16,18-19,21H,8-13H2,1-3H3,(H,26,30)(H,27,31);9,12-13,15-17H,4-8,10-11H2,1-3H3,(H,22,27)/t25-,26+,27?,29-;21-,22+,24-,25-;16-,18-,19+,21-;15-,16+,17-/m0000/s1
InChIKeyRTNWPJPCMPEHGL-NOXPZLBESA-N
XLogP14.23
TPSA469.31 Ų
H-Bond Donors7
H-Bond Acceptors24
Rotatable Bonds50
Heavy Atoms142
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001963.38
LogP ≤ 514.23
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}

Analyze (2R,5S)-6-(4-fluorophenyl)-5-methyl-2-(2-methylpropyl)-4-oxo-N-[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]hexanamide;N-[(2S,5R)-1-(4-fluorophenyl)-7-methyl-3-oxo-5-[[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]pyrazine-2-carboxamide;5-methyl-N-[(2S,5R)-7-methyl-1-naphthalen-1-yl-3-oxo-5-[[1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]-1,2-oxazole-3-carboxamide;(2R)-4-methyl-2-[2-(5-methyl-1,2-oxazol-3-yl)-2-oxoethyl]-N-[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]pentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R,5S)-6-(4-fluorophenyl)-5-methyl-2-(2-methylpropyl)-4-oxo-N-[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]hexanamide;N-[(2S,5R)-1-(4-fluorophenyl)-7-methyl-3-oxo-5-[[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]pyrazine-2-carboxamide;5-methyl-N-[(2S,5R)-7-methyl-1-naphthalen-1-yl-3-oxo-5-[[1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]-1,2-oxazole-3-carboxamide;(2R)-4-methyl-2-[2-(5-methyl-1,2-oxazol-3-yl)-2-oxoethyl]-N-[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]pentanamide?
The IUPAC name of (2R,5S)-6-(4-fluorophenyl)-5-methyl-2-(2-methylpropyl)-4-oxo-N-[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]hexanamide;N-[(2S,5R)-1-(4-fluorophenyl)-7-methyl-3-oxo-5-[[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]pyrazine-2-carboxamide;5-methyl-N-[(2S,5R)-7-methyl-1-naphthalen-1-yl-3-oxo-5-[[1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]-1,2-oxazole-3-carboxamide;(2R)-4-methyl-2-[2-(5-methyl-1,2-oxazol-3-yl)-2-oxoethyl]-N-[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]pentanamide (CID 160724646) is (2R,5S)-6-(4-fluorophenyl)-5-methyl-2-(2-methylpropyl)-4-oxo-N-[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]hexanamide;N-[(2S,5R)-1-(4-fluorophenyl)-7-methyl-3-oxo-5-[[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]pyrazine-2-carboxamide;5-methyl-N-[(2S,5R)-7-methyl-1-naphthalen-1-yl-3-oxo-5-[[1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]-1,2-oxazole-3-carboxamide;(2R)-4-methyl-2-[2-(5-methyl-1,2-oxazol-3-yl)-2-oxoethyl]-N-[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]pentanamide.
What is the SMILES notation for (2R,5S)-6-(4-fluorophenyl)-5-methyl-2-(2-methylpropyl)-4-oxo-N-[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]hexanamide;N-[(2S,5R)-1-(4-fluorophenyl)-7-methyl-3-oxo-5-[[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]pyrazine-2-carboxamide;5-methyl-N-[(2S,5R)-7-methyl-1-naphthalen-1-yl-3-oxo-5-[[1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]-1,2-oxazole-3-carboxamide;(2R)-4-methyl-2-[2-(5-methyl-1,2-oxazol-3-yl)-2-oxoethyl]-N-[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]pentanamide?
The canonical SMILES for (2R,5S)-6-(4-fluorophenyl)-5-methyl-2-(2-methylpropyl)-4-oxo-N-[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]hexanamide;N-[(2S,5R)-1-(4-fluorophenyl)-7-methyl-3-oxo-5-[[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]pyrazine-2-carboxamide;5-methyl-N-[(2S,5R)-7-methyl-1-naphthalen-1-yl-3-oxo-5-[[1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]-1,2-oxazole-3-carboxamide;(2R)-4-methyl-2-[2-(5-methyl-1,2-oxazol-3-yl)-2-oxoethyl]-N-[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]pentanamide is CC(C)C[C@H](CC(=O)[C@@H](C)Cc1ccc(F)cc1)C(=O)N[C@H](C=O)C[C@@H]1CCNC1=O.CC(C)C[C@H](CC(=O)[C@H](Cc1ccc(F)cc1)NC(=O)c1cnccn1)C(=O)N[C@H](C=O)C[C@@H]1CCCCC1=O.Cc1cc(C(=O)C[C@@H](CC(C)C)C(=O)N[C@H](C=O)C[C@@H]2CCCCC2=O)no1.Cc1cc(C(=O)N[C@@H](Cc2cccc3ccccc23)C(=O)C[C@@H](CC(C)C)C(=O)NC(C=O)C[C@@H]2CCCCC2=O)no1.
What is the InChIKey of (2R,5S)-6-(4-fluorophenyl)-5-methyl-2-(2-methylpropyl)-4-oxo-N-[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]hexanamide;N-[(2S,5R)-1-(4-fluorophenyl)-7-methyl-3-oxo-5-[[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]pyrazine-2-carboxamide;5-methyl-N-[(2S,5R)-7-methyl-1-naphthalen-1-yl-3-oxo-5-[[1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]-1,2-oxazole-3-carboxamide;(2R)-4-methyl-2-[2-(5-methyl-1,2-oxazol-3-yl)-2-oxoethyl]-N-[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]pentanamide?
The InChIKey is RTNWPJPCMPEHGL-NOXPZLBESA-N. The full InChI is InChI=1S/C34H41N3O6.C30H37FN4O5.C24H33FN2O4.C21H30N2O5/c1-21(2)15-26(33(41)35-27(20-38)17-25-10-5-7-14-31(25)39)19-32(40)29(36-34(42)30-16-22(3)43-37-30)18-24-12-8-11-23-9-4-6-13-28(23)24;1-19(2)13-22(29(39)34-24(18-36)15-21-5-3-4-6-27(21)37)16-28(38)25(14-20-7-9-23(31)10-8-20)35-30(40)26-17-32-11-12-33-26;1-15(2)10-19(13-22(29)16(3)11-17-4-6-20(25)7-5-17)24(31)27-21(14-28)12-18-8-9-26-23(18)30;1-13(2)8-16(11-20(26)18-9-14(3)28-23-18)21(27)22-17(12-24)10-15-6-4-5-7-19(15)25/h4,6,8-9,11-13,16,20-21,25-27,29H,5,7,10,14-15,17-19H2,1-3H3,(H,35,41)(H,36,42);7-12,17-19,21-22,24-25H,3-6,13-16H2,1-2H3,(H,34,39)(H,35,40);4-7,14-16,18-19,21H,8-13H2,1-3H3,(H,26,30)(H,27,31);9,12-13,15-17H,4-8,10-11H2,1-3H3,(H,22,27)/t25-,26+,27?,29-;21-,22+,24-,25-;16-,18-,19+,21-;15-,16+,17-/m0000/s1.
What are the key properties of (2R,5S)-6-(4-fluorophenyl)-5-methyl-2-(2-methylpropyl)-4-oxo-N-[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]hexanamide;N-[(2S,5R)-1-(4-fluorophenyl)-7-methyl-3-oxo-5-[[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]pyrazine-2-carboxamide;5-methyl-N-[(2S,5R)-7-methyl-1-naphthalen-1-yl-3-oxo-5-[[1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]-1,2-oxazole-3-carboxamide;(2R)-4-methyl-2-[2-(5-methyl-1,2-oxazol-3-yl)-2-oxoethyl]-N-[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]pentanamide?
(2R,5S)-6-(4-fluorophenyl)-5-methyl-2-(2-methylpropyl)-4-oxo-N-[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]hexanamide;N-[(2S,5R)-1-(4-fluorophenyl)-7-methyl-3-oxo-5-[[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]pyrazine-2-carboxamide;5-methyl-N-[(2S,5R)-7-methyl-1-naphthalen-1-yl-3-oxo-5-[[1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]-1,2-oxazole-3-carboxamide;(2R)-4-methyl-2-[2-(5-methyl-1,2-oxazol-3-yl)-2-oxoethyl]-N-[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]pentanamide has a molecular weight of 1963.38 g/mol, XLogP of 14.23, 50 rotatable bonds, 7 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,5S)-6-(4-fluorophenyl)-5-methyl-2-(2-methylpropyl)-4-oxo-N-[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]hexanamide;N-[(2S,5R)-1-(4-fluorophenyl)-7-methyl-3-oxo-5-[[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]pyrazine-2-carboxamide;5-methyl-N-[(2S,5R)-7-methyl-1-naphthalen-1-yl-3-oxo-5-[[1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]carbamoyl]octan-2-yl]-1,2-oxazole-3-carboxamide;(2R)-4-methyl-2-[2-(5-methyl-1,2-oxazol-3-yl)-2-oxoethyl]-N-[(2S)-1-oxo-3-[(1S)-2-oxocyclohexyl]propan-2-yl]pentanamide is sourced from PubChem (CID 160724646), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).